For the first time, a former U.S. state funeral directors association president publicly acknowledges the white fibrous clots: "They've been the size of the arteries.
by Nicolas Hulscher, MPH
Since
2021, reports of unusual white fibrous clots discovered during
embalming have been dismissed as anecdotal or attributed to fringe
voices within the profession. That dismissal is no longer credible. The
phenomenon is now being confirmed by senior leadership across multiple
funeral director and embalmer associations—individuals with decades of
experience and responsibility for representing thousands of
professionals.
In a recent 10-minute interview on OAN (watch full interview here),
2024-2025 President of the Pennsylvania Funeral Directors Association,
Chris Calvey Jr., reported that he has personally observed these white
fibrous clots in an astonishing 30% to 40% of the bodies he has embalmed over the past five years.
He
described the clots as being “the size of the arteries” and emphasized
that “you can’t ignore this.” Critically, he stated that these are
“foreign bodies” unlike anything he had encountered in his 10 years as a funeral director and embalmer.
This is not an isolated account. Just weeks earlier, Iowa Funeral Directors Association Board Member Dana Goodell independently reported observing the same type of unusual clotting—specifically noting that it began appearing around 2021.
Importantly, this phenomenon has now been acknowledged at the state association level. In June 2025, during the Tennessee Funeral Directors Association (TFDA) Convention, former USAF Major Thomas F. Haviland presented findings from an in-person survey conducted among 28 embalmers and funeral directors.
Nicolas Hulscher, MPH·17 June 2025Read full story
The results were alarming:
- 64% reported seeing white fibrous clots in corpses during the first half of 2025
- These clots appeared in an average of 17% of all bodies
- 70% reported signs of micro-clotting (“coffee grounds” or “dirty blood”)
- 39% observed an increase in infant deaths, averaging a 14% rise over pre-2020 levels
These findings were not merely written—they were confirmed in real time, as embalmers in the room raised their hands to verify that they had personally observed the phenomenon:
This event—facilitated by TFDA President Taylor Moore—marked the first formal acknowledgment by a U.S. state funeral directors association that these clots are real, prevalent, and ongoing.
According to documentation compiled by USAF Major (Ret.) Thomas F. Haviland, multiple high-ranking leaders within the funeral profession have now independently confirmed the presence of these clots:
- Woody Wilson — President, Ohio Embalmers Association (2024–2025)
- Taylor Moore — President, Tennessee Funeral Directors Association (2024–2025)
- Kevin Sweryd — President, Manitoba Funeral Service Association (Canada)
These
are not anonymous embalmers or isolated accounts. These are elected
leaders entrusted with representing the profession at the highest
levels.
THE BIOLOGICAL MECHANISM: FROM MICROCLOTS TO FIBROUS MASSES
A
growing body of evidence provides a plausible biological explanation
for the white fibrous clots now being reported by embalmers. Central to
this is the formation of amyloid, fibrinolysis-resistant microclots triggered by spike protein exposure—whether from SARS-CoV-2 infection or mRNA injections. In a recent peer-reviewed study, Thioflavin-T (ThT)-positive amyloid microclots were identified in 100% of participants within a heavily COVID-vaccinated cohort (94%),
including all “healthy controls.” These structures represent misfolded
fibrin with β-sheet amyloid configuration, fundamentally distinct from
normal clotting.
Nicolas Hulscher, MPH·18 November 2025Read full story
Mechanistic experiments within the same study demonstrated that spike protein alone can induce the formation of these insoluble, amyloid microclots in vitro, establishing a direct pathway for abnormal coagulation.
These microscopic findings closely align with postmortem observations. Independent forensic analyses have shown that the large white fibrous clots are amyloidogenic fibrin aggregates
that are protease-resistant, rubbery, and structurally dense—features
consistent with advanced-stage clot maturation. Their morphology and
biochemical properties mirror those of the microclots identified in
living subjects, but at a larger, aggregated scale.
Taken together, the data support a coherent progression: spike-induced amyloid microclots form in circulation, resist degradation, accumulate inflammatory material, and ultimately coalesce into large, fibrous intravascular structures.
A DIRECT CHALLENGE TO PUBLIC HEALTH AUTHORITIES
Thomas
Haviland, who has systematically documented and compiled these reports
from funeral professionals across the world, has now taken the
additional step of directly emailing U.S. public health leadership—including HHS, NIH, CDC, and FDA—urging them to investigate this phenomenon.
His message is clear and unambiguous: after nearly six years of
consistent reports from embalmers worldwide, how much more evidence is
required before a formal inquiry is initiated?
The reports
are now coming from presidents and senior officials of multiple funeral
director and embalmer associations, individuals with extensive
experience and professional accountability. The repeated description of
dense, fibrous, artery-shaped clots—unlike anything previously
encountered—has been independently corroborated across regions and over
time.
The continued absence of a coordinated response from federal health agencies now represents a serious dereliction of duty.
Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation